What is the intrinsic value of SYN?
As of 2025-07-25, the Intrinsic Value of Synthetic Biologics Inc (SYN) is
0.45 USD. This SYN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.02 USD, the upside of Synthetic Biologics Inc is
-55.91%.
Is SYN undervalued or overvalued?
Based on its market price of 1.02 USD and our intrinsic valuation, Synthetic Biologics Inc (SYN) is overvalued by 55.91%.
SYN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.45 - 0.45 |
0.45 |
-55.91% |
| P/E |
(0.20) - (0.47) |
(0.25) |
-124.4% |
| DDM - Stable |
(12.44) - (41.48) |
(26.96) |
-2742.9% |
| DDM - Multi |
(11.09) - (29.16) |
(16.12) |
-1680.5% |
SYN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
16.16 |
| Beta |
1.38 |
| Outstanding shares (mil) |
15.84 |
| Enterprise Value (mil) |
-17.87 |
| Market risk premium |
5.00% |
| Cost of Equity |
8.84% |
| Cost of Debt |
5.00% |
| WACC |
8.76% |